Overview of Generic Drugs and Drug Naming – Drugs – Merck Manuals Consumer Version, generic drug company.#Generic #drug #company

Posted On Jun 20 2018 by

Overview of Generic Drugs and Drug Naming By Daphne E. Smith Marsh, PharmD, BC-ADM, CDE , Clinical Assistant Professor, Department of Pharmacy Practice;Clinical Pharmacist, College of Pharmacy, University of Illinois at Chicago;Mile Square Health Center, University of Illinois at Chicago Brand-Name and Generic Drugs Drugs often have several names. When a drug is first discovered, it is given a chemical name, which describes the atomic or molecular structure of the drug. The chemical name is thus usually too complex and cumbersome for general use. Next, a shorthand version of the chemical name or a code name (such as RU 486) …


Generic Medicine – Gulf Drug Company, generic drug company.#Generic #drug #company

Posted On Jun 20 2018 by

generic drug company AT THE FOREFRONT OF GENERICS We will become Southern Africa’s most valued generic pharmaceutical company to patients, customers, business partners, and the communities in which we work and live. Our vision is to build GDC into a world class and leading generics pharmaceutical company, within a supportive and rewarding work environment for our employees, with presence across the continent. We are committed to improving the quality of people’s lives by manufacturing safe, cost effective, generic medicines to treat the country’s most common diseases. As a responsible corporate citizen, we are also committed to adopt policies and activities …


Drug Channels: Generic Deflation Roils the Channel – And Will Get Worse, generic drug company.#Generic #drug #company

Posted On Jun 20 2018 by

generic drug company Pages Thursday, August 10, 2017 Generic Deflation Roils the Channel And Will Get Worse Note that this index includes only products that had been generic for at least 12 months. This methodology eliminates the deflation that occurs when a brand-name drug loses exclusivity and faces generic competition. See Exhibit 138 in our 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. Red Oak Sourcing (CVS Health-Cardinal Health) Walgreens Boots Alliance Development (WBAD) Walgreens Boots Alliance with AmerisourceBergen McKesson OneStop and ClarusOne (with Walmart) Econdisc Contracting Solutions (Express Scripts and certain retail chains) In May 2017, Express …


Attorney General: Connecticut Leads 20 State Coalition Filing Federal Antitrust Lawsuit against Heritage Pharmaceuticals, other Generic Drug Companies, generic pharma companies.#Generic #pharma #companies

Posted On Jun 10 2018 by

generic pharma companies HARTFORD – Attorney General George Jepsen today joined with 19 other state attorneys general in filing a federal lawsuit against generic drug-makers Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. alleging that they entered into illegal conspiracies in order to unreasonably restrain trade, artificially inflate and manipulate prices and reduce competition in the United States for two drugs: doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication. The lawsuit was filed under seal in the U.S. District Court for the …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, generic pharma companies.#Generic #pharma #companies

Posted On Jun 9 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


Pharmaceutical Company in India, Ahmedabad, Pharma Company in India, Cadila Pharmaceuticals, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jun 9 2018 by

Formulations A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 ISO14001 accredited facilities at Ankleshwar, India Innovation Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse Manufacturing Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA About us Cadila Pharmaceuticals Limited, established in …


20 States Accuse Generic Drug Companies of Price Fixing, generic pharma companies.#Generic #pharma #companies

Posted On Jun 9 2018 by

The New York Times A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four smaller companies of engaging in brazen price-fixing schemes — and promised that more charges were coming. A civil complaint filed by 20 states accuses the companies of conspiring to artificially inflate prices on an antibiotic and a diabetes drug, with executives coordinating through informal industry gatherings and personal calls and text messages. Officials said the case was a small example of broader problems in the drug business. …


20 States Accuse Generic Drug Companies of Price Fixing – The New York Times, generic pharmaceuticals companies.#Generic #pharmaceuticals #companies

Posted On Jun 8 2018 by

20 States Accuse Generic Drug Companies of Price Fixing A wide-ranging investigation into generic drug prices took its most significant turn yet on Thursday, as state attorneys general accused two industry leaders, Teva Pharmaceuticals and Mylan, and four smaller companies of engaging in brazen price-fixing schemes — and promised that more charges were coming. A civil complaint filed by 20 states accuses the companies of conspiring to artificially inflate prices on an antibiotic and a diabetes drug, with executives coordinating through informal industry gatherings and personal calls and text messages. Officials said the case was a small example of broader …


Pharm Exec s Top 50 Companies 2016, Pharmaceutical Executive, top generic drug companies.#Top #generic #drug #companies

Posted On Jun 6 2018 by

top generic drug companies T hough the companies represented in the top 50 of global sales leaders have remained remarkably stable over time, their relative positioning within the list continues to shift. This reflects the importance that product launches and innovative campaigns to grow existing medications at every stage of the product life cycle now play in building a sales advantage against truly brutal levels of competition. It helps explain why Pfizer resumes its position this year as the industry s prescription sales leader, displacing Novartis in the No. 1 ranking by widening its therapeutic franchise in vaccines a segment …


Pharma companies fight behind-the-scenes wars over generic drugs, top generic drug companies.#Top #generic #drug #companies

Posted On Jun 6 2018 by

Pharma companies fight behind-the-scenes wars over generic drugs By Robin Feldman ll good things must come to an end” is a proverb that brand-name drug makers have trouble taking to heart. Just look at the strategies used to prevent competitors from bringing less-expensive generics to market. Pharmaceutical research has led to tremendous advances in medicine. Because of the extraordinarily high cost of bringing new drugs to the market, our intellectual property system is designed to ensure that drug companies recoup their investment and earn a profit. After a period of time, though, generic competitors are supposed to be able to …